In reply to: Association between utility and treatment among patients with prostate cancer.
This is a brief commentary in response to article-Jayadevappa et al. (Qual Life Res 19:711-729, 2010). The commentary draws attention to issues that complicate QoL assessments in generic and disease-specific measures and its association to the treatment.